| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |